Imatinib induces a cytogenetic response in blast crisis or interferon failure chronic myeloid leukemia patients with e19a2 BCR-ABL transcripts
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Link
http://www.nature.com/articles/2403454.pdf
Reference8 articles.
1. Saglio G, Guerrasio A, Rosso C, Zaccaria A, Tassinari A, Serra A et al. New type of Bcr/Abl junction in Philadelphia chromosome-positive chronic myelogenous leukemia. Blood 1990; 76: 1819–1824.
2. Pane F, Frigeri F, Sindona M, Luciano L, Ferrara F, Cimino R et al. Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction). Blood 1996; 88: 2410–2414.
3. Briz M, Vilches C, Cabrera R, Fores R, Fernandez MN . Typical chronic myelogenous leukemia with e19a2 junction BCR/ABL transcript. Blood 1997; 90: 5024–5025.
4. How GF, Tan LT, Lim LC . Chronic myeloid leukemia with e19a2 (c3a2) BCR/ABL fusion junction – is it truly a benign disease? Leukemia 1998; 12: 1166–1167.
5. Polak J, Koza V, Cetkovsky P, Haskovec C . An accelerated-phase CML patient with e19a2 junction of BCR/ABL gene – the first case of transplanted CML with micro bcr. Bone Marrow Transplant 2000; 25: 1109–1110.
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prognostic Significance of Transcript-Type BCR‐ABL1 in Chronic Myeloid Leukemia;Mediterranean Journal of Hematology and Infectious Diseases;2020-08-29
2. Chronic myeloid leukemia with a rare fusion transcript, e19a2 BCR–ABL1: A report of three cases from India;Annals of Diagnostic Pathology;2017-04
3. Molecular Response of e19a2 BCR-ABL1 Chronic Myeloid Leukemia With Double Philadelphia Chromosome to Dasatinib;Journal of Clinical Oncology;2016-05-10
4. Identification of Real MicroRNA Precursors with a Pseudo Structure Status Composition Approach;PLOS ONE;2015-03-30
5. Simple multiplex RT-PCR for identifying common fusion BCR-ABL transcript types and evaluation of molecular response of the a2b2 and a2b3 transcripts to Imatinib resistance in north Indian chronic myeloid leukemia patients;Indian Journal of Cancer;2015
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3